课题基金 / 基金详情

Characterization of B Cells in Dermatomyositis

Characterization of B Cells in Dermatomyositis
皮肌炎 B 细胞的特征
批准号:
7111992
负责人:
Elizabeth M Bradshaw
金额:
$4.88万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2009-03-31

项目摘要

项目成果

Elizabeth M Bradshaw的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):皮肌炎中,B细胞浸润肌肉组织。本提案的重点将首次允许检查直接来自皮肌炎患者肌肉组织的浸润性B细胞的抗原特异性,而没有先入为主的偏见。本文概述了研究皮肌炎免疫生物学的分子方法。单个B细胞将通过激光捕获显微解剖从肌肉活检标本中分离出来,随后进行PCR扩增和重、轻变量域测序。这些技术的结合将导致详细的地形和分子表征的B细胞皮肌炎。一旦B细胞被鉴定出来,就会产生大量的重组免疫球蛋白,并保留自然可变的重、轻配对,从而忠实地重建这些抗体,用于抗原筛选。这些抗体将用于识别驱动皮肌炎体液反应的自身抗原。
英文摘要
DESCRIPTION (provided by applicant): In dermatomyositis, B cells infiltrate the muscle tissue. The focus of this proposal will allow for the first time, examination of the antigen specificity of infiltrating B cells derived directly from muscle tissue of patients with dermatomyositis without preconceived bias. This proposal outlines molecular methods for studying the immunobiology of dermatomyositis. Single B cells will be isolated from muscle biopsy specimens by laser capture microdissection followed by PCR amplification and sequencing of the heavy and light variable domains. The combination of these techniques will lead to detailed topographic and molecular characterization of the B cells in dermatomyositis. Once the B cells have been characterized, large amounts of recombinant immunoglobulin will be generated, and the natural variable heavy and light pairing will be preserved allowing faithful reconstruction of these antibodies for antigen screening. These antibodies will be used to identify autoantigens driving the humoral response in dermatomyositis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intersection of HSV-1 and microglial genetics in AD
Intersection of HSV-1 and microglial genetics in AD
Microglia antigen presentation in the CNS of Alzheimer's disease
Microglia antigen presentation in the CNS of Alzheimer's disease
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究